Luminetx Corp. (Luminetx) has appointed Richard Kindberg as chief executive officer (CEO) of the company. Kindberg has more than 25 years of experience in healthcare. Prior to joining Luminetx, Kindberg served as divisional president for Durham, North Carolina-based Teleflex Medical, where he had full operational responsibility. He also held various senior management positions at C.R. Bard, Optical Biopsy Technologies, Focal Interventional, Richard-Allan Medical and Johnson & Johnson.

Kindberg has experience managing all facets of an organization including sales, marketing, operations and product development. Notably, he brings the unique perspective of someone who has successfully taken a breakthrough product, akin to the VeinViewer by Luminetx, and created new market awareness and acceptance.

“The Luminetx board is excited to bring a professional of this level to lead Luminetx going forward,” said Al Gossett, chairman of the Luminetx board. “2009 is going to be an important year for Luminetx, as we lay the foundation for continued growth to existing and new markets and Richard will lead that success. As interim CEO, it is a pleasure to hand over the reins to Richard as we have the utmost confidence in where he will take our company.”

“I am very excited to accept this appointment as CEO for Luminetx,” said Kindberg. “I feel the VeinViewer and Snowflake™ imaging technologies afford the company exciting new opportunities for expanded product line offerings in both the healthcare and biometrics markets. I look forward to working closely with the board of directors and Luminetx employees to continue to build our short- and long-term value for our shareholders and customers alike.”